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The RNA binding proteins Rbfox1/2/3 regulate alter-
native splicing in the nervous system, and disruption
of Rbfox1 has been implicated in autism. However,
comprehensive identification of functional Rbfox
targets has been challenging. Here, we perform
HITS-CLIP for all three Rbfox family members in
order to globally map, at a single-nucleotide resolu-
tion, their in vivo RNA interaction sites in the mouse
brain.Wefind that the twoguanines in theRbfoxbind-
ing motif UGCAUG are critical for protein-RNA inter-
actions and crosslinking. Using integrative modeling,
these interaction sites, combined with additional
datasets, define 1,059 direct Rbfox target alternative
splicing events. Over half of the quantifiable targets
show dynamic changes during brain development.
Of particular interest are 111 events from 48
candidate autism-susceptibility genes, including syn-
dromic autism genes Shank3, Cacna1c, and Tsc2.
Alteration of Rbfox targets in some autistic brains is
correlated with downregulation of all three Rbfox
proteins, supporting the potential clinical relevance
of the splicing-regulatory network.
INTRODUCTION
The Rbfox proteins are a family of neuron- and muscle/heart-
specific RNA binding proteins (RBPs) encoded by three
genes—Rbfox1 (Fox-1 or A2bp1), Rbfox2 (Fox-2 or Rbm9), and
Rbfox3 (Fox-3, Hrnbp3, or NeuN)—that are conserved in verte-
brates, flies, and worms. Rbfox1 and Rbfox2 are exclusively orCepreferentially expressed in neurons, heart, and muscles,
whereas Rbfox3 is specifically expressed in postmitotic neu-
rons. In humans, chromosomal translocation or copy number
variation affecting RBFOX1 has been found in patients with
several neurological disorders, including epilepsy, intellectual
disability (Bhalla et al., 2004), schizophrenia (Xu et al., 2008),
and autism (Martin et al., 2007; Sebat et al., 2007).
At the molecular level, Rbfox proteins are known as tissue-
specific splicing factors that bind to the (U)GCAUG element
frequently conserved across vertebrate species (Jin et al.,
2003; Minovitsky et al., 2005; Ponthier et al., 2006; Underwood
et al., 2005). We previously performed genome-wide bio-
informatic prediction of Rbfox target exons based on phyloge-
netically conserved motif sites (Zhang et al., 2008), leading to
the identification of >1,000 alternative or constitutive exons
that are potentially regulated by Rbfox, many found within tran-
scripts encoding proteins important for neuromuscular func-
tions. Characterization of the splicing pattern of the Rbfox
targets revealed a position-dependent RNA map predictive of
Rbfox action. According to this map, Rbfox binding in the
downstream intron activates exon inclusion and binding in the
alternative exon or upstream intron represses exon inclusion,
consistent with observations from several tissue-specific exons
(Jin et al., 2003; Underwood et al., 2005). Such a map was pre-
viously found for another neuron-specific splicing factor Nova
and is now recognized as a more general rule of alternative
splicing regulation (Licatalosi et al., 2008; Ule et al., 2006).
Despite recent progress (Barash et al., 2010; Ray et al., 2013;
Ule et al., 2006; Zhang et al., 2013), the small sizes of RBP bind-
ing motifs limit the ability of motif-based bioinformatic target
prediction to achieve both high specificity and sensitivity. To
map in vivo protein-RNA interaction sites on a genome-wide
scale, crosslinking and immunoprecipitation followed by high-
throughput sequencing (HITS-CLIP) have been developed toll Reports 6, 1139–1152, March 27, 2014 ª2014 The Authors 1139
Figure 1. HITS-CLIP Maps Rbfox-RNA Interaction Sites in Mouse Brain on a Genome-wide Scale
(A) A schematic illustration of two HITS-CLIP protocols used to map Rbfox binding sites.
(B) A UCSC Genome Browser view of Rbfox1, 2, and 3 CLIP data in an alternatively spliced region of a 93 nt cassette exon in Rbfox1 is shown. Rbfox1, 2, and 3
CLIP data are shown in separate wiggle tracks above the coordinates of UGCAUG and GCAUG elements and the phyloP conservation score.
(legend continued on next page)
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isolate RNA fragments directly bound by an RBP of interest
(Darnell, 2010; Licatalosi et al., 2008; Moore et al., 2014; Ule
et al., 2005a). HITS-CLIP has been used to map the Rbfox2
binding sites in thousands of genes in human embryonic stem
cells, including those important for splicing regulation as
predicted by the RNA map (Yeo et al., 2009).
To understand the physiological function of Rbfox proteins in
the mammalian brain, knockout (KO) mouse models have been
generated. CNS-specific depletion of Rbfox1 results in an
increased susceptibility of mice to seizures and in overex-
citability of neurons in the dentate gyrus (Gehman et al., 2011).
CNS depletion of Rbfox2 results in defects in cerebellar develop-
ment (Gehman et al., 2012). Comparison of wild-type (WT)
versus Rbfox1 or Rbfox2 KObrains using exon-junctionmicroar-
rays has identified multiple Rbfox-dependent exons (Gehman
et al., 2011, 2012). However, the number of exons identified
using this approach is quite small (20 and 29 exons, respec-
tively), compared to the number of Rbfox binding sites deter-
mined by bioinformatic prediction or CLIP data, presumably
due to compensatory upregulation of Rbfox2 in Rbfox1 KO
mice and vice versa. Given that different Rbfox family members
have highly similar protein sequences, especially in their
RNA-recognition motif (RRM)-type RNA binding domain
(RBD; R94% amino acid identity), they are expected to bind
and regulate largely overlapping sets of transcripts (Gallagher
et al., 2011; Gehman et al., 2012).
Until now, a comprehensive and accurate target splicing-
regulatory network of the Rbfox proteins has not been defined,
due in part to the lack of a genome-wide high-resolution map
of the Rbfox interaction sites in the brain and to the lack of effec-
tive computational methods to couple protein-RNA interactions
with splicing changes as a means of identifying direct, functional
targets. Here, we used HITS-CLIP to globally map the RNA inter-
action sites of all three Rbfox family members and comple-
mented the CLIP data with RNA sequencing (RNA-seq) data to
identify exons responsive to perturbation of Rbfox. Importantly,
we probabilistically weighed and combined these and additional
data sets to define the functional target transcripts directly regu-
lated by Rbfox using an integrative modeling approach (Zhang
et al., 2010). The resulting network allowed us to reveal the role
of Rbfox proteins in regulating global dynamic splicing changes
during brain development and highlight promising downstream
targets implicated in autism.
RESULTS
Rbfox1, 2, and 3 HITS-CLIP in Mouse Brain
Considering the possibility that each Rbfox family member might
differ in binding specificity despite their apparent functional(C) Similar to (B), except that the alternatively spliced region ofGabrg2 exon 9 is s
track with different colors representing the CLIP tags obtained in independent C
(top right).
(D and E) Genomic distribution of Rbfox1, 2, and 3 CLIP tags pooled togethe
incompleteness of 50 and 30 UTR annotations, each gene is extended for 10 kb i
(F) Pairwise correlation of CLIP data among Rbfox proteins based on the number o
three-dimensional (3D) space. Comparisons between each pair of proteins are sh
space (colored dots). Pearson correlation of each pairwise comparison is indica
(G) Correlation of CLIP tags derived from the standard and BrdU-CLIP protocols
Ceredundancy, we performed HITS-CLIP experiments for all mem-
bers of the family individually using mouse whole-brain tissue.
We first confirmed that the antibodies we used did not cross-
react with different members and that they efficiently immuno-
precipitated (IP) the targeted protein with minimal background
under standard CLIP conditions (Figure S1; Supplemental
Notes). Next, we used two different strategies to clone and
amplify the isolated RNA fragments (Figure 1A). The first pro-
tocol, denoted as standard CLIP, was performed as described
previously (Darnell, 2010; Licatalosi et al., 2008; Moore et al.,
2014; Ule et al., 2005a). In this protocol, RNA linkers are ligated
to the 50 and 30 ends of the RNA fragments (Figure 1A, left branch)
and are later used for RT-PCR amplification. We and several
other groups have previously noted that after proteinase Kdiges-
tion of the crosslinked protein-RNA complex, one or a few amino
acids might remain attached to the RNA at the crosslink site,
which causes informative errors at the crosslink site during
reverse transcription (Granneman et al., 2009; Ule et al.,
2005a). These crosslinking-induced mutation sites (CIMS)
provide a footprint of protein-RNA crosslinking and can be lever-
aged to determine protein-RNA interactions at a single nucleo-
tide resolution (Moore et al., 2014; Zhang and Darnell, 2011).
However, reverse transcription can abort prematurely at these
sites, resulting in truncated cDNAs that lack the 50 adaptor
required for PCR (Ko¨nig et al., 2010; Sugimoto et al., 2012). To
capture both truncated and nontruncated cDNAs, we developed
a second CLIP protocol named bromodeoxyuridine (BrdU)-CLIP
(Figure 1A, right branch). This protocol bears some conceptual
similarity to individual nucleotide resolution CLIP or iCLIP (Ko¨nig
et al., 2010). After ligation of the 30 linker, purified RNA is reverse
transcribed to introduce 50 and 30 PCR adaptor sequences sepa-
rated by an apurinic/apyrimidinic endonuclease (APE) cleavage
site. This is followed by the circularization of both readthrough
and truncated cDNAs and relinearization of cDNA via the
cleavage site to place the 50 and 30 adaptor sequences in the
correct orientation. One key difference between BrdU-CLIP
and iCLIP is the incorporation of BrdUTP into the cDNA during
reverse transcription so that the resulting cDNA can be purified
in a stringent manner using an antibody that specifically recog-
nizes BrdU (Core et al., 2008; Ingolia et al., 2009).
To evaluate the robustness of the Rbfox interaction sites, we
prepared HITS-CLIP libraries for Rbfox1, Rbfox2, and Rbfox3
with four, four, and five biological replicates, respectively, which
together resulted in about 870million raw reads (CLIP tags). After
stringent filtering, processing, and mapping (Moore et al., 2014;
Zhang et al., 2010) (Experimental Procedures), we obtained a
total of 4.6 million unique CLIP tags that represent independent
captures of protein-RNA interactions, including 1,460,387 tags
for Rbfox1, 868,366 tags for Rbfox2, and 2,308,632 tags forhown. CLIP data of Rbfox1, 2, and 3 are pooled together and shown in a single
LIP experiments. The position of Nova binding is indicated by the arrowhead
r (D), and the resulting genic CLIP tag cluster peaks (E) are shown. Due to
n both directions; these regions are listed as separate categories.
f CLIP tags per cluster. Each cluster is represented as a black dot positioned in
own in 2D planes, obtained by projecting the black dots into their respective 2D
ted.
, based on the number of CLIP tags per cluster.
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Rbfox3. Between 59% and 65% of these CLIP tags are located
in introns, consistent with the known role of Rbfox proteins in
regulating alternative splicing; an additional 23%–28% unique
CLIP tags are located in exons, mostly in the 30 UTRs.
Rbfox1, 2, and 3 Have Similar Protein-RNA Interaction
Profiles
Initial inspection of the CLIP tag distribution suggests that the
interaction profiles of the three Rbfox family members are very
similar. For example, the Rbfox1 transcripts contain a cassette
exon of 93 nt (Figure 1B) encoding part of the RRM of the protein.
Its skipping as a result of autoregulation generates a dominant-
negative form that lacks RNA binding capability (Baraniak
et al., 2006; Damianov and Black, 2010). Our CLIP data show
that all three Rbfox family members bind to the upstream intronic
sequences harboring a cluster of conserved UGCAUG elements,
suggesting that this exon is under both auto- and cross-regula-
tion by all family members. We also previously demonstrated
that GABA receptor gamma 2 subunit (Gabrg2) exon 9 is under
the synergistic regulation of Rbfox and Nova when they bind
near the 50 and 30 splice sites of the downstream intron, respec-
tively, based on detailed mutation analysis and splicing reporter
assays in cell culture (Dredge and Darnell, 2003; Zhang et al.,
2010). Our CLIP data now confirmed that Rbfox proteins indeed
bind to the expected site in vivo in the brain (Figure 1C).
To quantitatively compare the RNA binding profiles of different
Rbfox familymembers, we defined a nonredundant set of Rbfox-
RNA interaction sites using all unique CLIP tags pooled together
(Figure 1D; Experimental Procedures). A stringent set of 41,182
genic CLIP tag clusters with at least one statistically significant
peak (p < 0.01) was obtained (Table S1), 70% of which are
located in introns and the other 30% are in exons (Figure 1E).
Then, we counted the number of CLIP tags per cluster for each
protein. CLIP tags for different members are very well correlated
in each pairwise comparison, especially between Rbfox1 and
Rbfox3 (Pearson correlation R = 0.97); the correlation between
Rbfox2 and the other two members is somewhat lower (R =
0.76–0.80; Figure 1F). In addition, we confirmed that the two
CLIP protocols gave very reproducible results in the global
profiles (R = 0.97; Figure 1G). Based on these observations,
we conclude that the three Rbfox family members have similar
RNA-interaction profiles on a genome-wide scale, consistent
with the notion that their binding specificity is largely determined
by their very similar RRMs. Although it remains possible that a
small proportion of the binding sites could be preferentially
recognized by a specific member, for this work, CLIP tags of
all three members were pooled together for further analysis.
A Single-Nucleotide Resolution Map of Rbfox Binding
Sites by CIMS and CITS Analysis
Using two CLIP protocols in parallel allowed us to employ
different strategies to pinpoint the exact Rbfox-RNA crosslink
and interaction sites (Figures 2 and S2). For CLIP tags obtained
by the standard protocol, we performed CIMS analysis using our
established method (Figure 2A) (Moore et al., 2014; Zhang and
Darnell, 2011). Nucleotide deletions were observed in 14% of
standard CLIP tags, from which 1,424 reproducible CIMS were
identified (false discovery rate [FDR] < 0.001). A substantial1142 Cell Reports 6, 1139–1152, March 27, 2014 ª2014 The Authorsenrichment of the Rbfox binding motif GCAUG was observed
in the immediate vicinity of the reproducible deletion sites (Fig-
ure 2B). In contrast, when we analyzed substitutions and inser-
tions using the same method, we did not observe elevated motif
enrichment near the mutation sites (data not shown), suggesting
that crosslinking predominantly, if not exclusively, introduces
deletions rather than insertions or substitutions in Rbfox CLIP.
We then examined the enrichment of UGCAUG or VGCAUG
(V = non-U) relative to the crosslink sites with reproducible dele-
tions in more detail (Figure 2B inset). UGCAUG is enriched 28- to
41-fold at positions 5, 4, and 1 relative to the crosslink site,
corresponding to crosslinking at G2, U5, and G6 of the UGCAUG
element. Interestingly, enrichment of VGCAUG is most predom-
inant at position 1 relative to the crosslink site (64-fold), corre-
sponding to crosslinking of G2 (Figure 2C). We also examined
the base composition of the sequences around CIMS regardless
of the presence of (U)GCAUG and observed a slight bias toward
uridine compared to the flanking sequences (Figure S2A; see
Discussion below). De novo motif analysis using sequences
[-10,10] around CIMS uncovered (U)GCAUG as the only motif
with strong enrichment (36% of 1,158 nonrepetitive CIMS in
[10,10], E < 3.7 3 10320; Figure S2B). The first position of
the motif is the most variable, which is consistent with previous
findings that Rbfox binds to both UGCAUG and VGCAUG with
high affinity (Jin et al., 2003; Ponthier et al., 2006). Additional
deviations from the consensus appear to be tolerated to some
extent (e.g., in positions 3 and 4), providing a partial explanation
for why (U)GCAUG is not present at all crosslink sites (Figures
S2E–S2G). Finally, we observed deletions in 6.2% of BrdU-
CLIP tags, and analysis combining standard and BrdU-CLIP
tags defined 2,298 CIMS (FDR < 0.001; Table S2).
The sensitivity of crosslink site identification by CIMS analysis
is limited by the relatively low deletion rate among tags that are
read through. We therefore looked for reproducible crosslinking
induced truncation sites (CITS) in BrdU-CLIP data (Figure 2D;
Experimental Procedures). Overall, 6,606 robust CITS were
identified (p < 0.001; Table S3). Among these, the UGCAUG
element is enriched 319-fold at a single position (5) relative to
CITS, corresponding to predominant crosslinking at G6 of the
motif (Figure 2E). The same position was crosslinked in the
VGCAUG element, although there is less enrichment of the motif
(88-fold; Figure 2F). Analysis of the base composition [10,10]
around CITS revealed the UGCAUG motif directly (Figure S2C),
and this was confirmed by de novo motif analysis (60% of
1000 randomly sampled nonrepetitive sites; E < 1.9 3 10631;
Figure S2D). As a control, we repeated the same analysis in
the standard CLIP data, which presumably lacked truncated
tags, and did not observe enrichment of the (U)GCAUG motif
in these specific positions (Figures S2H and S2I).
Together, our data suggest that the two guanines G2 andG6 in
the (U)GCAUG motif are particularly prone to crosslinking with
the Rbfox protein. Consistent with this finding, examination of
a previously determined NMR structure of the Rbfox1 RRM in
complex with UGCAUGU RNA revealed that these two guanines
are buried in two pockets of the RRM and are stabilized by
multiple hydrogen bonds and stacking interactions (Figure 2G);
mutations in each of these two nucleotides resulted in the largest
increases in the free energy of binding (Auweter et al., 2006).
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Figure 2. CIMS and CITS Analysis to Map Rbfox-RNA Interactions at a Single-Nucleotide Resolution
(A)–(C) and (D)–(F) are for crosslinking-induced mutation sites (CIMS) and crosslinking-induced truncation sites (CITS) analysis, respectively.
(A and D) A schematic illustration of CIMS (A) and CITS (D) is shown.
(B and E) Enrichment of UGCAUG around CIMS (deletions, B) and CITS (truncations, E) is calculated from the frequency of UGCAUG starting at each position
relative to the inferred crosslink sites, normalized by the frequency of the element in flanking sequences. The inset shows a zoomed-in view, with the most
frequent crosslink sites in the motif highlighted in red.
(C and F) Similar to (B) and (E), except that the enrichment of VGCAUG (V = non-U) around CIMS (C) and CITS (F) is shown.
(G) NMR structure of RbFox1 RRM (surface, pale blue) in complex with the UGCAUGU heptanucleotide (cartoon, rainbow; Protein Data Bank ID code 2ERR;
Auweter et al., 2006). Highlighted are the two guanines G2 and G6 (pink) with predominant crosslinking.Based on the single-nucleotide-resolution map of in vivo Rbfox
interaction sites and on the characterized specificity of the
proteins, we developed the motif enrichment and conservation
score (MECS) of (U)GCAUG elements by comparing CLIP tag
clusters and regions without CLIP tags (Figures S2J and S2K;
Supplemental Results). A motif site with higher conservation
receives a higher score, especially if it is located in an intronic
region. A UGCAUG element receives a higher score than a
VGCAUG element with the same level of conservation, reflecting
greater enrichment of the former in CLIP tag clusters.
Identifying Rbfox-Dependent Exons Using RNA-Seq
We previously used HeLa cells with perturbed Rbfox1 or Rbfox2
expression to validate over half (55%–59%) of bioinformatically
predicted Rbfox target alternative exons tested with RT-PCR
(Zhang et al., 2008). We therefore used this established experi-
mental system to expand the list of Rbfox-dependent exons by
RNA-seq, which provides information complementary to the
CLIP data. As we described previously (Zhang et al., 2008),
HeLa cells were treated with a short hairpin RNA (shRNA) target-
ing Rbfox2 (shRbfox2) to generate stable knockdown (KD) of theCeprotein, which is endogenously expressed at a level that is low
but sufficient for splicing regulation; HeLa cells expressing the
empty vector were used for comparison (control; Figure 3A,
left panel). In total, RNA-seq of the control and shRbfox2
samples resulted in 60 million and 48 million paired-end reads,
respectively, of which 62%–65% were mapped unambiguously
to the genome or to the exon-junction database. Examination
of the gene-expression level confirmed that Rbfox2 was specif-
ically knocked down 3.3-fold (Figure 3A, right panel), consistent
with the protein level changes observed from immunoblot anal-
ysis. Accordingly, we were able to identify 126 cassette exons,
17 tandem cassette exon events, and four mutually exclusive
exon events showing Rbfox2-dependent inclusion or exclu-
sion (FDR % 0.1 and proportional change of exon inclusion
jDIj R 0.1) (Ule et al., 2005b) (Figure 3B; Table S4). Among the
22 cases of alternative exons we tested by RT-PCR (which in-
cludes three cases with a read coverage slightly below the
threshold we used), 21 showed Rbfox2-dependent splicing (Fig-
ures 3C and 3D; Tables S4 and S5), giving a validation rate of
95%. The direction of Rbfox2-dependent splicing of these exons
can be predicted by the position-dependent RNA map based onll Reports 6, 1139–1152, March 27, 2014 ª2014 The Authors 1143
Figure 3. Identification of Rbfox2-Dependent Exons using RNA-Seq
(A) Left panel: Rbfox2 protein expression in HeLa cells with stable knockdown of Rbfox2 using a specific shRNA (shRbfox2) compared with cells treated with the
vector (control), as evaluated by immunoblot analysis. The nucleosome remodeling complex protein SNF is used as a loading control. Right panel: the gene
expression profiles in HeLa cells treated with shRbfox2 or control vectors are quantified by reads per kb/million (RPKM) using RNA-seq data. Rbfox2 is high-
lighted by the red circle.
(B) Proportional inclusion (I) of cassette exons in shRbfox and control HeLa cells. Exons with reduced and increased inclusion (FDR < 0.1 and jDIj > 0.1; Ule et al.,
2005b) in shRbfox2 compared with control HeLa cells are highlighted in red and blue, respectively.
(C and D) UCSC Genome Browser views of two examples of Rbfox-dependent exon inclusion (PICALM, C) or exclusion (MAP3K7, D), as indicted by the
arrowheads in (B). Below the RNA-seq data are (U)GCAUG elements and phyloP conservation scores. The result of RT-PCR validation is shown on the right.either the CLIP data derived from mouse brain or the bio-
informatically predicted motif sites (data not shown), indicating
that these Rbfox2-dependent exons are enriched in direct Rbfox
targets in the brain.
Integrative Modeling Defines the Rbfox Target Splicing-
Regulatory Network
To comprehensively define the functional target network directly
regulated by the Rbfox proteins, we took an integrative modeling
approach, which we have recently developed, and successfully
applied it to study the Nova target network (Zhang et al., 2010).
This method uses a Bayesian network to probabilistically weigh
and combine multiple types of data complementary to each
other: bioinformatically predicted motif sites represented by
MECS scores, protein-RNA interaction sites mapped by Rbfox
HITS-CLIP, Rbfox1-dependent splicing identified by com-
parison of WT with Rbfox1 KO mouse brain using exon-junction
microarrays (Gehman et al., 2011), Rbfox2-dependent splicing in
HeLa cells as described above, tissue-specific splicing as
measured by RNA-seq (only for training; Brawand et al., 2011),
and evolutionary signatures including preservation of reading1144 Cell Reports 6, 1139–1152, March 27, 2014 ª2014 The Authorsframe and conservation of alternative splicing pattern (Figure 4A;
Experimental Procedures).
Focusing initially on cassette exons, we found that the esti-
mated model parameters confirmed, quantified, and extended
our understanding of Rbfox splicing regulation (Figures 4B–4E
and S3A–S3E; Supplemental Results). For example, stronger
motif sites are more likely to be bound by the protein (Figure 4B),
and regions inferred to be bound by Rbfox have more CLIP tags
than those inferred not to be bound (Figure 4C). In addition, the
model was able to quantify the position-dependent RNA map:
binding of Rbfox in the downstream intron is predicted to result
in Rbfox-dependent inclusion with a probability of 0.99, whereas
binding of Rbfox in the upstream intron or exon is predicted
to result in repression with a probability of 0.75 and 0.61,
respectively. Binding of Rbfox in both exon and upstream intron
is expected to increase the probability of repression to 0.84
(Figure 4D).
The model was then applied to each annotated cassette exon
in themouse genome to predict the probability of its activation or
repression by Rbfox through direct protein-RNA interactions.
After using 10-fold cross-validation to ensure the model was
Figure 4. Integrative Modeling Predicts Rbfox Target Exons using a Bayesian Network
The model is trained using cassette exons.
(A) Design of the Bayesian network (BN). The 17 nodes (variables) model four types of data, including (U)GCAUG elements and CLIP tag clusters in each cassette
exon or flanking upstream (UI) and downstream introns (DI), splicing change of exons with Rbfox depletion or among different tissues, and evolutionary
signatures.
(B) The probability of Rbfox binding to regions with varying motif scores.
(C) The cumulative probability of CLIP tag cluster scores across all regions with or without inferred Rbfox binding.
(D) The probability of exons showing Rbfox-dependent inclusion (red), exclusion (blue), or no effect (gray), given the indicated combinatorial Rbfox binding
patterns in the exon (E), upstream (U), and downstream (D) introns.
(E) The distribution of proportional splicing changes (DI) in Rbfox knockdown versus the control as measured by RNA-seq for exons with inferred Rbfox-
dependent inclusion, exclusion, or without Rbfox regulation.
(F) Rbfox binding pattern for exons predicted to be activated or repressed by Rbfox, or exons for which the direction of Rbfox regulation cannot be determined
unambiguously. In each group, exons are ranked by the confidence of prediction (left). (U)GCAUGmotif scores, CLIP tag cluster scores, and inferred probability of
Rbfox binding at different positions of the alternatively spliced region are shown in the grayscale heatmaps (darker colors represent stronger binding). UI5, E5, and
DI5 represent regions near the 50 splice sites of the upstream intron, exon, and downstream intron, respectively; Similarly, UI3, E3, and DI3 represent regions near
the 30 splice sites.not overfit (Figure S3F), we predicted 772 cassette exons as
direct Rbfox targets (FDR < 0.05; Table S6). Among these
targets, Rbfox was predicted to activate 421 exons (probability
of activation >0.7) and repress 113 exons (probability of repres-
sion >0.7), respectively. For the remaining 238 exons predicted
as Rbfox targets, the Bayesian network was unable to assign
the direction of regulation unambiguously (Figure 4F, left panel).
This uncertainty is presumably due to a lack of observed Rbfox-
dependent splicing in the current experimental settings and to
binding of Rbfox in both upstream and downstream introns
simultaneously (Figure 4F, right panel). Based on comparison
of the predicted exons with previously validated Rbfox-regulated
exons compiled from the literature, we estimated that our
Bayesian network analysis has a sensitivity of 73%–79%
(Supplemental Results; Figure S4; Table S7). We also compared
the results of the Bayesian network analysis to our previous
motif-based bioinformatic predictions and to another recent
study that predicted Rbfox target exons based on the presence
of the Rbfox motif sites and the correlation of exon splicing with
Rbfox expression (Ray et al., 2013). These comparisons showed
substantial overlap between exons predicted by different
methods but also highlighted that the Bayesian network analysis
effectively integrated features known to be consistent with
regulated alternative splicing events, such as preservation ofCethe reading frame and conservation of the alternative splicing
pattern (Figure S5; Supplemental Results).
After we confirmed the performance of the Bayesian network,
we applied themodel to other types of alternative splicing events
and predicted 212 events of tandem cassette exons (300 exons,
Table S6) and 75 events of mutually exclusive exons (107 exons,
TableS6) asdirect Rbfox targets. Altogether, 587genes haveone
or more alternative splicing events directly regulated by Rbfox.
To understand the molecular function of these genes, we
performedgeneontology (GO) analysis and foundvery significant
enrichment of genes with annotated function in ‘‘cytoskeleton’’
(Benjamini FDR < 3.8 3 1017) and ‘‘neuron projection’’ (Benja-
mini FDR < 3.83 108), compared to all brain-expressing genes
(Table S8). In addition, proteins encoded by Rbfox target
transcripts are enriched in PDZ domains that are known to be
important for anchoring transmembrane proteins to the cytoskel-
eton and for functioning as scaffolds for signaling complexes
(Benjamini FDR < 7.2 3 108) (Ranganathan and Ross, 1997).
Rbfox Regulates Global Dynamic Splicing Changes
during Brain Development
It has previously been shown that all three Rbfox familymembers
undergo increased expression in the mouse brain at pre-
natal stages between embryonic day E12 and E18 (Tang et al.,ll Reports 6, 1139–1152, March 27, 2014 ª2014 The Authors 1145
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Figure 5. Rbfox Regulates Global
Dynamic Splicing Changes during Brain
Development
(A) Rbfox1, 2, and 3 expression in embryonic
(green) or adult cortex (blue) as quantified by
RNA-seq data. Error bars represent SEM.
(B) The proportion of Rbfox target exons and
nontarget exons with developmental splicing
changes. The difference is evaluated by Fisher’s
exact test.
(C) Rbfox target exons are divided into two
groups depending on whether Rbfox activates or
represses exon inclusion. For each group, the
number of exons showing higher (blue) or lower
(green) inclusion in the adult versus embryonic
cortex is shown. The direction of developmental
splicing change is compared with the direction
of Rbfox regulation, as assessed by Fisher’s
exact test.2009), and that the increase of Rbfox1 expression further
extends into postnatal stages (Hammock and Levitt, 2011). In
mouse and chicken, the differential expression of Rbfox proteins
is correlated with splicing changes in several exons during CNS
development (Kim et al., 2013; Tang et al., 2009), but how Rbfox
proteins affect the global switch of the developmental splicing
program is unclear.
We found that Rbfox family members undergo dynamic
changes in expression between E17 and adult mouse cortex,
as evaluated from a published RNA-seq data set (Dillman
et al., 2013). Rbfox1 and Rbfox3 show 1.6-fold (p < 0.02; t test)
and 3.1-fold (p < 106; t test) increases in the adult cortex
compared to E17 cortex, respectively, whereas the expression
of Rbfox2 is reduced 3.1-fold (p < 104; t test; Figure 5A). The
expression changes of the Rbfox proteins parallel the splicing
changes of Rbfox target exons: 55% of Rbfox target exons
with sufficient read coverage to quantify splicing show splicing
changes between the two developmental stages, as compared
to 32% for exons not regulated by Rbfox (odds ratio = 2.4, p <
7.63 1016; Fisher’s exact test; Figure 5B). In addition, a major-
ity (77%) of the exons activated by Rbfox have increased exon
inclusion in the adult, whereas over half (57%) of the exons
repressed by Rbfox have decreased exon inclusion (odds ratio =
4.4, p < 0.003; Fisher’s exact test; Figure 5C). This asymmetry
indicates that increased expression of Rbfox1 and Rbfox3 pre-
dominates the developmental splicing change of their targets,
and in general they promote the switch to the adult splicing pro-
gram through direct regulation.
Rbfox Target Genes Are Linked to Autism
We previously demonstrated that Rbfox target transcripts pre-
dicted bioinformatically based on conserved motif sites have
significant overlap with genes implicated in autism, supporting
the notion that disruption of either Rbfox1 itself or of its targets
observed in autism patients is likely pathogenic (Zhang et al.,
2010). This hypothesis was further supported by recent findings
that RBFOX1 is a hub in gene coexpression networks based
on microarray profiling of autistic and control postmortem
human brains, and its reduced expression in a subset of autism
patients is correlated with altered splicing of predicted Rbfox1146 Cell Reports 6, 1139–1152, March 27, 2014 ª2014 The Authorstarget exons (Voineagu et al., 2011). The comprehensive Rbfox
target network defined by integrative modeling now allows us
to examine the link between RBFOX1 and autism in more detail.
Among the 235 Rbfox target cassette exons that are
conserved in human and that have sufficient RNA-seq read
coverage to evaluate splicing change in autistic versus control
brains (Voineagu et al., 2011), 97 (41%) show alteration of
splicing in autistic brains (jDIjR 0.1, and FDR% 0.05), a very sig-
nificant overlap compared to random chance (odds ratio = 3.4,
p< 1.43 1016; Fisher’s exact test; Figure 6A). The autistic brains
compared here were selected to have low expression level of
Rbfox1 (Voineagu et al., 2011) (4.1-fold downregulation com-
pared to control brains as measured by RNA-seq; p < 0.05,
t test; Figure 6B). However, themassive splicing change of Rbfox
targets detected in autistic versus control brains is somewhat
surprising given the redundant role of the other Rbfox family
members, as observed in Rbfox1 KO mice (Gehman et al.,
2011, 2012). Interestingly, we found that the expression of the
other two family members, Rbfox2 and Rbfox3, was also down-
regulated 3.3-fold (p < 0.05; t test) and 3.2-fold (p < 0.09; t test),
respectively. Therefore, simultaneous downregulation of all
Rbfox family members might explain the massive splicing misre-
gulation of Rbfox target exons observed in these autism patients.
On the other hand, many of the splicing changes observed in
autism patients may not be regulated by Rbfox proteins directly.
To focus on Rbfox target genes that are likely genetic risk
factors of autism, we examined candidate autism-susceptibility
genes in the SFARI autism gene database (Basu et al., 2009).
Among the 519 candidate autism-susceptibility genes with
mouse orthologs, 48 were identified as Rbfox targets by
Bayesian network analysis (odds ratio = 2.8, p < 9.6 3 1018,
Fisher’s exact test; Table 1 and Table S6). The list includes three
genes that are currently regarded as causal in syndromic
autism spectrum disorders (ASDs): Shank3 (Phelan-McDermid
Syndrome), Cacna1c (Timothy syndrome), and Tsc2 (tuberous
sclerosis complex). For a specific example, Rbfox is predicted
to activate the inclusion of alternative exon 25 in the Tsc2
gene, which is conserved between human and mouse (Fig-
ure 6C). Although the function of this alternative exon has not
been characterized, its inclusion was recently shown to be
A B
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Figure 6. Rbfox Target Exons in Candidate Autism-Susceptibility Genes
(A) Overlap between Rbfox target cassette exons and exons with altered splicing in autistic versus control brains.
(B) Downregulation of Rbfox1, 2, and 3 expression in autistic versus control brains as quantified by RNA-seq. Error bars represent SEM.
(C) Rbfox is predicted to activate the inclusion of a 129 nt exon in the Tsc2 gene. Below the gene structure schematic are RNA-seq data of different tissues
showing a higher inclusion of the exon in cortex and heart, pooled Rbfox CLIP tags, Rbfox binding UGCAUG or GCAUG elements, and the phyloP
conservation score.
(D) Rbfox is predicted to activate the inclusion of an 84 nt poisonous exon in the Scn2a1 gene, which creates an in-frame premature termination codon (PTC)
conserved in vertebrates.dependent on Rbfox2 using cell culture models of epithelial-to-
mesenchymal transition (Braeutigam et al., 2013).
Inclusion or exclusion of Rbfox target exons mostly introduces
alteration in local amino acid sequences. However, we identified
several cases (Fat1, St7, Scn2a1, and Scn8a) in which alternative
splicing is potentially coupled with nonsense-mediated mRNA
decay (NMD; Maquat, 2004). In Scn2a1, for instance, Rbfox is
predicted to activate a cryptic exon harboring an in-frame
premature stop codon via extensive binding to the downstream
intron (Figure 6D). Inclusion of this exon is undetectable in the
brain from RNA-seq data, presumably due to NMD of the
inclusion isoform. Interestingly, whereas this alternative exon is
conserved in vertebrates, compensatory mutations in the stop
codon have accumulated. This has resulted in different stop
codons in different species, suggesting an evolutionary selection
pressure to preserve a stop codon. Scn2a1 is one of the few
genes with recurrent de novo gene-disrupting mutations
according to exome sequencing of ASD patients (Ronemus
et al., 2014), and our analysis suggests that the same gene can
potentially be disrupted in autism by different mechanisms.
We tested a select set of exons in potentially autism-related
genes for regulation by Rbfox1 in the mouse brain. The splicing
level of these exons was measured in CNS-specific Rbfox1-KO
mouse brains compared to WT controls by semiquantitativeCeRT-PCR. Among eight exons for which both the inclusion and
exclusion isoforms can be detected, three exons showed altered
splicing upon Rbfox1 depletion (jDIjR 0.1; Figure S6; Table S5),
and these were not identified as Rbfox1 targets in the previous
genome-wide analysis (Gehman et al., 2011). The relatively small
number of validated exons is likely due to the redundancy of
Rbfox proteins and the compensatory increase of Rbfox2 protein
expression inRbfox1KOanimals (Gehman et al., 2011), although
it is possible that some of the predicted targets might represent
false-positives.
DISCUSSION
The focus of this study is to define and characterize the Rbfox
target splicing-regulatory network in the mammalian brain. An
important piece of information missing in previous efforts toward
this aim (e.g., Fogel et al., 2012; Gehman et al., 2011, 2012; Ray
et al., 2013; Zhang et al., 2008) is a genome-wide, high-resolu-
tion map of in vivo Rbfox interaction sites in the brain. Such a
map is especially essential due to the functional redundancy of
different Rbfox family members, so that simultaneous depletion
of more than one member is probably required to uncover a
majority of Rbfox-dependent exons in a physiologically relevant
condition. A critical aspect of this work is our ability to identifyll Reports 6, 1139–1152, March 27, 2014 ª2014 The Authors 1147
Table 1. List of Rbfox Target Genes Implicated in Autism
Entrez Gene ID
(Mouse) Gene Symbol Tissue Expression
Autism versus Control Splicing
Change Function
11538 Adnp non-brain-specific transcription factor
11784 Apba2 brain-specific Y neurotransmitter release
11789 Apc non-brain-specific Wnt signaling
11941 Atp2b2 brain-specific calmodulin binding
319974 Auts2 non-brain-specific unknown
30948 Bin1 non-brain-specific Y synaptic vesicle endocytosis
12288 Cacna1c non-brain-specific ion channel
12289 Cacna1d non-brain-specific ion channel
12291 Cacna1g non-brain-specific ion channel
54725 Cadm1 non-brain-specific Y cell adhesion
320405 Cadps2 non-brain-specific Y synaptic vesicle exocytosis
100072 Camta1 non-brain-specific calmodulin binding
67300 Cltc non-brain-specific receptor localization
104318 Csnk1d non-brain-specific cell signaling
74006 Dnm1l non-brain-specific mitochondrial and peroxisomal
division
75560 Ep400 non-brain-specific chromatin binding
13876 Erg non-brain-specific transcription factor
14107 Fat1 non-brain-specific cell adhesion
268566 Gphn non-brain-specific receptor localization
74053 Grip1 non-brain-specific glutamate receptor binding
108071 Grm5 brain-specific G-protein coupled receptor
227753 Gsn non-brain-specific Y cytoskeleton
14886 Gtf2i non-brain-specific Y transcription factor
16531 Kcnma1 brain-specific Y ion channel
242274 Lrrc7 brain-specific synapse assembly
18027 Nfia non-brain-specific transcription factor
319504 Nrcam brain-specific Y cell adhesion
18189 Nrxn1 brain-specific cell adhesion
18191 Nrxn3 brain-specific cell adhesion
80883 Ntng1 brain-specific cell adhesion
233977 Ppfia1 non-brain-specific Y cell signaling
353211 Prune2 non-brain-specific Y unknown
268859 Rbfox1 non-brain-specific RNA metabolism
268902 Robo2 non-brain-specific axon guidance
110876 Scn2a1 brain-specific ion channel
20273 Scn8a brain-specific ion channel
58234 Shank3 non-brain-specific synapse assembly
76376 Slc24a2 brain-specific ion transport
72055 Slc38a10 non-brain-specific ion/amino acid transport
94229 Slc4a10 brain-specific ion transport
64213 St7 non-brain-specific cell signaling
53416 Stk39 non-brain-specific serine/threonine kinase
20910 Stxbp1 non-brain-specific Y neurotransmitter release
64009 Syne1 non-brain-specific Y cytoskeleton
22084 Tsc2 non-brain-specific chaperone
22138 Ttn low-brain-expression sarcomere structure
(Continued on next page)
1148 Cell Reports 6, 1139–1152, March 27, 2014 ª2014 The Authors
Table 1. Continued
Entrez Gene ID
(Mouse) Gene Symbol Tissue Expression
Autism versus Control Splicing
Change Function
22214 Ube2h non-brain-specific protein ubiquitination
68134 Upf3b non-brain-specific mRNA metabolism
Tissue specificity of gene expression is based on the RNA-seq data set in Brawand et al. (2011), and splicing change in autistic versus control brains is
based on the RNA-seq data in Voineagu et al. (2011). Gene function was compiled from the literature.over 40,000 robust Rbfox binding sites using two HITS-CLIP
protocols applied in parallel to each of the three Rbfox family
members. These include 8,811 sites (2,298 CIMS and 6,606
CITS with 93 common sites) for which the exact site of protein-
RNA crosslinking can be deduced, allowing for determination
of protein-RNA interactions at a single nucleotide resolution.
The overall distribution of Rbfox binding sites defined by
HITS-CLIP is generally consistent with a recently published inde-
pendent study (Lovci et al., 2013).
Detailed analysis of Rbfox-RNA crosslink sites provided
insights into the biophysical principles of protein-RNA cross-
linking. UV crosslinking of protein and RNA was thought to be
most efficient for the nucleotide uridine. This presumptive prefer-
ence was used to interpret the U stretch enriched in sequences
around CIMS and in iCLIP data for several RBPs including Nova,
Ago, hnRNP C, and TIA (Sugimoto et al., 2012), despite the fact
that these proteins have a genuine binding preference for uridine.
Therefore, the predominant crosslinking of Rbfox and substrate
RNA at the two guanines in the (U)GCAUG motif, as suggested
by CIMS andCITS analysis, is somewhat unexpected, especially
given the presence of two uridines in the motif. We argue that
these crosslink sites likely reflect the residues in closest contact
with the protein or those interacting with specific amino acids,
which agrees very well with a structure study of the protein-
RNA complex (Auweter et al., 2006). Additional evidence sup-
porting this argument comes from predominant crosslinking to
different nucleotides for several other RBPs with distinct binding
specificity (Moore et al., 2014). On the other hand, we also
observed that a substantial proportion of Rbfox-RNA crosslink
sites do not overlap with the canonical Rbfox (U)GCAUG motif.
Paradoxically, when these sites were included for analysis, the
base composition at CIMS identified in Rbfox CLIP data is
slightly biased toward uridine. One possible interpretation for
this discrepancy is that some of these sites without the Rbfox
motif might have resulted from crosslinking of more transient
protein-RNA interactions largely independent of the Rbfox spec-
ificity (e.g., recruitment by other interacting RBPs), which would
suggest that preferential crosslinking to uridine indeed exists to
some extent. However, for high-affinity protein-RNA interac-
tions, such ‘‘background’’ preference does not prevent UV
crosslinking at specific nucleotides in the core motif.
It has been reported that the rate of cDNA truncation at the
crosslink site during reverse transcription is as high as 82% for
Nova and over 95% for several other RBPs (Sugimoto et al.,
2012). Based on the relative frequency of deletions in Rbfox
CLIP tags obtained with standard and BrdU-CLIP protocols
(14% versus 6.2%), we estimated that 57% of Rbfox CLIP tags
are truncated at the crosslink sites (Experimental Procedures).CeTherefore, this parameter could vary substantially for different
proteins, depending on the specific amino acid(s) and nucleo-
tide(s) at the crosslink sites, and possibly also on different exper-
imental conditions.
The second critical aspect of this study is the use of an integra-
tive modeling approach to combine multiple complementary
types of data, so that individually weak bits of information can
be integrated tomake strong predictions of Rbfox targets (Zhang
et al., 2010). Because increasing amounts of high-throughput
data are being produced for different RBPs, interrogating RNA
regulation from different perspectives, such a method has the
unique advantage of being able to identify direct, functional
target transcripts with high specificity and sensitivity simulta-
neously. Wewere able to assign the direction of Rbfox regulation
for a majority of Rbfox targets (69% of cassette exons), which
allowed us to evaluate the impact of splicing regulation by Rbfox
proteins in different physiological contexts, including brain
development and autism.
Our analysis extends previous observations regarding the
differential expression of Rbfox family members during brain
development (Hammock and Levitt, 2011; Kim et al., 2013;
Tang et al., 2009) by showing increased expression of Rbfox1
and Rbfox3 and decreased expression of Rbfox2 in adult
compared to a late prenatal stage. Similar dynamic changes in
Rbfox1 and Rbfox2 expression were previously observed in
the heart during postnatal development (Kalsotra et al., 2008).
Importantly, differential expression of Rbfox is paralleled by
developmental splicing changes in over half of the quantifiable
Rbfox target exons, frequently in the direction consistent with
direct Rbfox regulation. Combined with neurodevelopmental
defects observed in cell cultures (Kim et al., 2013), animal
models (Gehman et al., 2011, 2012; Kim et al., 2013), and human
patients (Bhalla et al., 2004) where Rbfox proteins are disrupted,
this presents a compelling case for Rbfox proteins playing
critical roles in driving the global dynamic change of the develop-
mental splicing-regulatory program.
Given the strong implication of Rbfox1 in autism and the role of
Rbfox proteins in neural development, we are particularly inter-
ested in the molecular mechanisms underlying ASD cases with
mutations in RBFOX1. One hypothesis of the autism etio-
pathology is that many genes implicated in autism can be dis-
rupted individually in cis by mutations in the genes themselves,
or in trans by disruption of their upstream regulators such as
Rbfox1. This hypothesis was supported both by the significant
overlap between candidate autism-susceptibility genes and
Rbfox target genes and by the significant overlap of predicted
Rbfox target exons and exons altered in autistic brains with
downregulation of Rbfox1 (Voineagu et al., 2011). Importantly,ll Reports 6, 1139–1152, March 27, 2014 ª2014 The Authors 1149
we found that all Rbfox family members are downregulated in
some autistic brains, underscoring the potential clinical rele-
vance of the Rbfox target network in autism. In addition, we
were able to highlight 48 genes in the SFARI autism gene data-
base as direct Rbfox targets. The functions of these genes,
which include cytoskeleton and scaffolding, synaptic transmis-
sion, ion channels, and transcription regulation, are potentially
relevant to the neurobiology underlying autism.
We note that this study is aimed at defining the pan-Rbfox
alternative splicing target network as ameans of elucidating their
molecular functions. We are currently limited in our ability to
comprehensively identify target transcripts differentially regu-
lated by the three family members individually. An outstanding
question is the extent to which the Rbfox family members have
distinct physiological functions and the underlying molecular
mechanisms for these potential differences. Our CLIP data sug-
gest that all three members have very similar protein-RNA inter-
action profiles, indicating that the highly conserved RRM is the
major determinant of targeting specificity. However, the func-
tional divergence of the different members could arise from the
increased variation in the N-terminal and C-terminal regions,
which were shown to also be important in splicing regulation
(Jin et al., 2003; Nakahata and Kawamoto, 2005; Sun et al.,
2012). For example, different members might recruit different
cofactors and exert different regulatory effects depending on
cellular context. However, addressing this question will require
expression of different combinations of Rbfox proteins in physi-
ologically relevant systems, a currently nontrivial experiment.
Such data, when available, will nevertheless further improve
the accuracy of our model by correlating them with protein-
RNA interactions and other types of data specific to individual
Rbfox family members.
Finally, another important question beyond the scope of this
work concerns the roles of Rbfox in the regulation of other path-
ways in RNA metabolism. Several recent findings propose that
Rbfox can also regulate alternative polyadenylation (Wang
et al., 2008) and mRNA stability (Ray et al., 2013), based on
analysis of Rbfox motif sites in 30 UTRs that are correlated with
transcript abundance in different tissues. Although the current
data supporting the role of Rbfox in these processes are largely
correlative, they are corroborated by our observation that almost
30% of Rbfox binding sites are in 30 UTRs. A mechanistic under-
standing of the functional impact of Rbfox interacting with 30
UTRs awaits further investigation. We expect that the data pre-
sented in this work will provide a valuable resource to facilitate
these efforts.EXPERIMENTAL PROCEDURES
All animal-related procedures were conducted according to the Institutional
Animal Care and Use Committee guidelines at Columbia University Medical
Center and the Rockefeller University.
HITS-CLIP Experiments Using Mouse Brain
Antibodies used in HITS-CLIP experiments for individual Rbfox members were
tested to ensure that there is no or minimal cross-reactivity between family
members and to optimize the signal-to-noise ratios of IP in the CLIP condition.
Rbfox1, 2, and 3 CLIP experiments were performed with whole-brain tissue
lysate of P15 CD1 mice using two different protocols. The standard CLIP1150 Cell Reports 6, 1139–1152, March 27, 2014 ª2014 The Authorslibraries were prepared as described previously (Darnell, 2010; Licatalosi
et al., 2008; Moore et al., 2014). Details of the BrdU-CLIP protocol are
described in the Supplemental Experimental Procedures.
Bioinformatic analysis of CLIP data was performed essentially as described
previously to obtain unique CLIP tags and define CLIP tag clusters and peaks
(Charizanis et al., 2012; Moore et al., 2014; Zhang and Darnell, 2011). Muta-
tions in unique CLIP tags were recorded for CIMS analysis as described
previously (Moore et al., 2014; Zhang and Darnell, 2011). CITS analysis was
performed using a computational method similar to that used to analyze iCLIP
data with several modifications (Ko¨nig et al., 2010; Wang et al., 2010). We
removed CLIP tags with deletions, which presumably had read through the
crosslink sites and clustered the remaining tags based on their potential
truncation sites, and then used a stringent statistical test to evaluate the signif-
icance of the observed truncation frequency.
RNA-Seq in HeLa Cells
HeLa cells were infected with murine-stem-cell-virus-expressing shRbfox2 or
the empty retroviral vector (control) (Zhang et al., 2008). To reduce splicing pre-
cursors and intermediates, cells were fractionated to enrich cytoplasmic RNA
before sequencing. The downstream analysis was performed as described
previously (Charizanis et al., 2012) except that the proportional change of
exon inclusion was estimated using the ASPIRE algorithm (Ule et al., 2005b).
RT-PCR Validation
Semiquantitative RT-PCR in HeLa cells was performed as described previ-
ously (Zhang et al., 2008). For RT-PCR validation, total RNA was extracted
from brains ofWT and homozygousRbfox1KOmice. Candidate exons for vali-
dation were selected to cover the whole range of prediction confidence, avoid-
ing exons with complex splicing patterns or very high or low inclusion levels.
Integrative Modeling Using Bayesian Network Analysis
We used our established Bayesian network framework with some modifica-
tions (Zhang et al., 2010). We considered differential splicing between WT
and Rbfox1 KO mouse brain, differential splicing between shRbfox2 and con-
trol HeLa cells, tissue-specific splicing of exons in cortex and cerebellum
compared to other tissues (liver, kidney, and testis), and tissue-specific
splicing of exons in heart compared to other tissues (liver, kidney, and testis).
For motif sites, we considered both UGCAUG and VGCAUG elements, and
measured their strength by their MECS score.
To train the model, we used 121 cassette exons compiled from the literature
that have been previously validated as Rbfox targets in humans or mice and
assigned them a class label (activation or repression). We also included unla-
beled exons that showed relatively large or no changes in inclusion in exon-
junction microarray or RNA-seq data. This resulted in 551 nonredundant
exons, representing both targets and nontargets, to estimate model parame-
ters. The trained Bayesian network model was applied to 16,034 cassette
exons, as well as 4,074 events of tandem cassette exons and 960 events of
mutually exclusive exons, to predict direct Rbfox targets.
Details of all experimental protocols and computational analyses are
described in the Supplemental Experimental Procedures.
ACCESSION NUMBERS
Rbfox HITS-CLIP and RNA-seq data were deposited to the NCBI Short Reads
Archive under accession number SRP035321.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Results, Supplemental
Experimental Procedures, six figures, and eight tables and can be found
with this article online at http://dx.doi.org/10.1016/j.celrep.2014.02.005.
AUTHOR CONTRIBUTIONS
C.Z. and R.B.D. initiated this study. A.M. developed the BrdU-CLIP protocol.
C.Z. optimized and performed Rbfox HITS-CLIP experiments in the R.B.D.
lab. S.S. and Z.Z. generated HeLa cell RNA-seq data. S.M.W.-V. and C.Z.
performed bioinformatics analysis with assistance from C.X. Q.Y. and M.H.
performed the mouse work and collected WT and Rbfox1 KO brain samples.
S.S. and Q.Y. performed experimental validation of Rbfox targets in HeLa cells
and mouse brains, respectively. N.F. and P.A.S. produced the Rbfox3
polyclonal antibody and performed the initial analysis. M.Q.Z., A.R.K.,
R.B.D., and C.Z. supervised the study. S.M.W.-V., Q.Y., and C.Z. wrote the
paper with input from all authors.
ACKNOWLEDGMENTS
The authors would like to thank Masato Yano for generating pRbfox3 plasmid,
Joe Luna for methodological development assistance, Yuan Yuan andMichael
Moore for helpful discussion, Scott Dewell for high-throughput sequencing,
Melis Kayikci and Jernej Ule for ASPIRE analysis, Jinbiao Ma and Judith
Kribelbauer for assistance with the interpretation of the Rbfox1-RNA complex
structure data, and Judith Kribelbauer for assistance with the preparation of
Figure 2G. This work was supported by grants from the National Institutes of
Health (GM74688 and HG001696 to M.Q.Z., GM42699 to A.R.K., NS81706
and NS34389 to R.B.D., and R00GM95713 to C.Z.) and Simons Foundation
Autism Research Initiative (240432 to R.B.D. and 297990 to C.Z.). R.B.D. is
a Howard Hughes Medical Institute Investigator.
Received: September 22, 2013
Revised: November 30, 2013
Accepted: February 4, 2014
Published: March 6, 2014
REFERENCES
Auweter, S.D., Fasan, R., Reymond, L., Underwood, J.G., Black, D.L., Pitsch,
S., and Allain, F.H.-T. (2006). Molecular basis of RNA recognition by the human
alternative splicing factor Fox-1. EMBO J. 25, 163–173.
Baraniak, A.P., Chen, J.R., and Garcia-Blanco, M.A. (2006). Fox-2 mediates
epithelial cell-specific fibroblast growth factor receptor 2 exon choice. Mol.
Cell. Biol. 26, 1209–1222.
Barash, Y., Calarco, J.A., Gao, W., Pan, Q.,Wang, X., Shai, O., Blencowe, B.J.,
and Frey, B.J. (2010). Deciphering the splicing code. Nature 465, 53–59.
Basu, S.N., Kollu, R., and Banerjee-Basu, S. (2009). AutDB: a gene reference
resource for autism research. Nucleic Acids Res. 37 (Database issue), D832–
D836.
Bhalla, K., Phillips, H.A., Crawford, J., McKenzie, O.L.D., Mulley, J.C., Eyre, H.,
Gardner, A.E., Kremmidiotis, G., and Callen, D.F. (2004). The de novo chromo-
some 16 translocations of two patients with abnormal phenotypes (mental
retardation and epilepsy) disrupt the A2BP1 gene. J. Hum. Genet. 49,
308–311.
Braeutigam, C., Rago, L., Rolke, A., Waldmeier, L., Christofori, G., and Winter,
J. (2013). The RNA-binding protein Rbfox2: an essential regulator of EMT-
driven alternative splicing and a mediator of cellular invasion. Oncogene
http://dx.doi.org/10.1038/onc.2013.50.
Brawand, D., Soumillon, M., Necsulea, A., Julien, P., Csa´rdi, G., Harrigan, P.,
Weier, M., Liechti, A., Aximu-Petri, A., Kircher, M., et al. (2011). The evolution of
gene expression levels in mammalian organs. Nature 478, 343–348.
Charizanis, K., Lee, K.-Y., Batra, R., Goodwin, M., Zhang, C., Yuan, Y., Shiue,
L., Cline, M., Scotti, M.M., Xia, G., et al. (2012). Muscleblind-like 2-mediated
alternative splicing in the developing brain and dysregulation in myotonic
dystrophy. Neuron 75, 437–450.
Core, L.J., Waterfall, J.J., and Lis, J.T. (2008). Nascent RNA sequencing
reveals widespread pausing and divergent initiation at human promoters.
Science 322, 1845–1848.
Damianov, A., and Black, D.L. (2010). Autoregulation of Fox protein expression
to produce dominant negative splicing factors. RNA 16, 405–416.
Darnell, R.B. (2010). HITS-CLIP: panoramic views of protein-RNA regulation in
living cells. Wiley Interdiscip Rev. RNA 1, 266–286.CeDillman, A.A., Hauser, D.N., Gibbs, J.R., Nalls, M.A., McCoy, M.K., Rudenko,
I.N., Galter, D., and Cookson, M.R. (2013). mRNA expression, splicing and
editing in the embryonic and adult mouse cerebral cortex. Nat. Neurosci. 16,
499–506.
Dredge, B.K., and Darnell, R.B. (2003). Nova regulates GABA(A) receptor g2
alternative splicing via a distal downstream UCAU-rich intronic splicing
enhancer. Mol. Cell. Biol. 23, 4687–4700.
Fogel, B.L., Wexler, E., Wahnich, A., Friedrich, T., Vijayendran, C., Gao, F.,
Parikshak, N., Konopka, G., and Geschwind, D.H. (2012). RBFOX1 regulates
both splicing and transcriptional networks in human neuronal development.
Hum. Mol. Genet. 21, 4171–4186.
Gallagher, T.L., Arribere, J., Adkar, S., Marr, H., Dill, K., Garnett, A., Amacher,
S., and Conboy, J. (2011). Fox1 and Fox4 regulate muscle-specific splicing in
zebrafish and are required for cardiac and skeletal muscle functions. Dev. Biol.
344, 491–492.
Gehman, L.T., Stoilov, P., Maguire, J., Damianov, A., Lin, C.-H., Shiue, L., Ares,
M., Jr., Mody, I., and Black, D.L. (2011). The splicing regulator Rbfox1 (A2BP1)
controls neuronal excitation in the mammalian brain. Nat. Genet. 43, 706–711.
Gehman, L.T., Meera, P., Stoilov, P., Shiue, L., O’Brien, J.E., Meisler, M.H.,
Ares, M., Jr., Otis, T.S., and Black, D.L. (2012). The splicing regulator Rbfox2
is required for both cerebellar development and mature motor function. Genes
Dev. 26, 445–460.
Granneman, S., Kudla, G., Petfalski, E., and Tollervey, D. (2009). Identification
of protein binding sites on U3 snoRNA and pre-rRNA by UV cross-linking
and high-throughput analysis of cDNAs. Proc. Natl. Acad. Sci. USA 106,
9613–9618.
Hammock, E.A.D., and Levitt, P. (2011). Developmental expression mapping
of a gene implicated in multiple neurodevelopmental disorders, A2bp1
(Fox1). Dev. Neurosci. 33, 64–74.
Ingolia, N.T., Ghaemmaghami, S., Newman, J.R.S., and Weissman, J.S.
(2009). Genome-wide analysis in vivo of translation with nucleotide resolution
using ribosome profiling. Science 324, 218–223.
Jin, Y., Suzuki, H., Maegawa, S., Endo, H., Sugano, S., Hashimoto, K.,
Yasuda, K., and Inoue, K. (2003). A vertebrate RNA-binding protein Fox-1
regulates tissue-specific splicing via the pentanucleotide GCAUG. EMBO J.
22, 905–912.
Kalsotra, A., Xiao, X., Ward, A.J., Castle, J.C., Johnson, J.M., Burge, C.B., and
Cooper, T.A. (2008). A postnatal switch of CELF and MBNL proteins repro-
grams alternative splicing in the developing heart. Proc. Natl. Acad. Sci.
USA 105, 20333–20338.
Kim, K.K., Nam, J., Mukouyama, Y.S., and Kawamoto, S. (2013). Rbfox3-
regulated alternative splicing of Numb promotes neuronal differentiation
during development. J. Cell Biol. 200, 443–458.
Ko¨nig, J., Zarnack, K., Rot, G., Curk, T., Kayikci, M., Zupan, B., Turner, D.J.,
Luscombe, N.M., and Ule, J. (2010). iCLIP reveals the function of hnRNP
particles in splicing at individual nucleotide resolution. Nat. Struct. Mol. Biol.
17, 909–915.
Licatalosi, D.D., Mele, A., Fak, J.J., Ule, J., Kayikci, M., Chi, S.W., Clark, T.A.,
Schweitzer, A.C., Blume, J.E., Wang, X., et al. (2008). HITS-CLIP yields
genome-wide insights into brain alternative RNA processing. Nature 456,
464–469.
Lovci, M.T., Ghanem, D., Marr, H., Arnold, J., Gee, S., Parra, M., Liang, T.Y.,
Stark, T.J., Gehman, L.T., Hoon, S., et al. (2013). Rbfox proteins regulate
alternative mRNA splicing through evolutionarily conserved RNA bridges.
Nat. Struct. Mol. Biol. 20, 1434–1442.
Maquat, L.E. (2004). Nonsense-mediated mRNA decay: splicing, translation
and mRNP dynamics. Nat. Rev. Mol. Cell Biol. 5, 89–99.
Martin, C.L., Duvall, J.A., Ilkin, Y., Simon, J.S., Arreaza, M.G., Wilkes, K.,
Alvarez-Retuerto, A., Whichello, A., Powell, C.M., Rao, K., et al. (2007). Cyto-
genetic and molecular characterization of A2BP1/FOX1 as a candidate gene
for autism. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 144B, 869–876.
Minovitsky, S., Gee, S.L., Schokrpur, S., Dubchak, I., and Conboy, J.G. (2005).
The splicing regulatory element, UGCAUG, is phylogenetically and spatiallyll Reports 6, 1139–1152, March 27, 2014 ª2014 The Authors 1151
conserved in introns that flank tissue-specific alternative exons. Nucleic Acids
Res. 33, 714–724.
Moore, M.J., Zhang, C., Gantman, E.C., Mele, A., Darnell, J.C., and Darnell,
R.B. (2014). Mapping Argonaute and conventional RNA-binding protein inter-
actions with RNA at single-nucleotide resolution using HITS-CLIP and CIMS
analysis. Nat. Protoc. 9, 263–293.
Nakahata, S., and Kawamoto, S. (2005). Tissue-dependent isoforms of
mammalian Fox-1 homologs are associated with tissue-specific splicing
activities. Nucleic Acids Res. 33, 2078–2089.
Ponthier, J.L., Schluepen, C., Chen, W., Lersch, R.A., Gee, S.L., Hou, V.C., Lo,
A.J., Short, S.A., Chasis, J.A., Winkelmann, J.C., and Conboy, J.G. (2006).
Fox-2 splicing factor binds to a conserved intron motif to promote inclusion
of protein 4.1R alternative exon 16. J. Biol. Chem. 281, 12468–12474.
Ranganathan, R., and Ross, E.M. (1997). PDZ domain proteins: scaffolds for
signaling complexes. Curr. Biol. 7, R770–R773.
Ray, D., Kazan, H., Cook, K.B., Weirauch, M.T., Najafabadi, H.S., Li, X.,
Gueroussov, S., Albu, M., Zheng, H., Yang, A., et al. (2013). A compendium
of RNA-binding motifs for decoding gene regulation. Nature 499, 172–177.
Ronemus, M., Iossifov, I., Levy, D., and Wigler, M. (2014). The role of de novo
mutations in the genetics of autism spectrum disorders. Nat. Rev. Genet. 15,
133–141.
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T.,
Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007). Strong association
of de novo copy number mutations with autism. Science 316, 445–449.
Sugimoto, Y., Ko¨nig, J., Hussain, S., Zupan, B., Curk, T., Frye, M., and Ule, J.
(2012). Analysis of CLIP and iCLIPmethods for nucleotide-resolution studies of
protein-RNA interactions. Genome Biol. 13, R67.
Sun, S., Zhang, Z., Fregoso, O., and Krainer, A.R. (2012). Mechanisms of
activation and repression by the alternative splicing factors RBFOX1/2. RNA
18, 274–283.
Tang, Z.Z., Zheng, S., Nikolic, J., and Black, D.L. (2009). Developmental con-
trol of CaV1.2 L-type calcium channel splicing by Fox proteins. Mol. Cell. Biol.
29, 4757–4765.
Ule, J., Jensen, K., Mele, A., and Darnell, R.B. (2005a). CLIP: a method for
identifying protein-RNA interaction sites in living cells. Methods 37, 376–386.
Ule, J., Ule, A., Spencer, J., Williams, A., Hu, J.-S., Cline, M., Wang, H., Clark,
T., Fraser, C., Ruggiu, M., et al. (2005b). Nova regulates brain-specific splicing
to shape the synapse. Nat. Genet. 37, 844–852.1152 Cell Reports 6, 1139–1152, March 27, 2014 ª2014 The AuthorsUle, J., Stefani, G., Mele, A., Ruggiu, M., Wang, X., Taneri, B., Gaasterland, T.,
Blencowe, B.J., andDarnell, R.B. (2006). An RNAmap predicting Nova-depen-
dent splicing regulation. Nature 444, 580–586.
Underwood, J.G., Boutz, P.L., Dougherty, J.D., Stoilov, P., and Black, D.L.
(2005). Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal
splicing regulators in mammals. Mol. Cell. Biol. 25, 10005–10016.
Voineagu, I., Wang, X., Johnston, P., Lowe, J.K., Tian, Y., Horvath, S., Mill, J.,
Cantor, R.M., Blencowe, B.J., and Geschwind, D.H. (2011). Transcriptomic
analysis of autistic brain reveals convergent molecular pathology. Nature
474, 380–384.
Wang, E.T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., King-
smore, S.F., Schroth, G.P., and Burge, C.B. (2008). Alternative isoform regula-
tion in human tissue transcriptomes. Nature 456, 470–476.
Wang, Z., Kayikci, M., Briese, M., Zarnack, K., Luscombe, N.M., Rot, G.,
Zupan, B., Curk, T., and Ule, J. (2010). iCLIP predicts the dual splicing effects
of TIA-RNA interactions. PLoS Biol. 8, e1000530.
Xu, B., Roos, J.L., Levy, S., van Rensburg, E.J., Gogos, J.A., and Karayiorgou,
M. (2008). Strong association of de novo copy numbermutations with sporadic
schizophrenia. Nat. Genet. 40, 880–885.
Yeo, G.W., Coufal, N.G., Liang, T.Y., Peng, G.E., Fu, X.-D., and Gage, F.H.
(2009). An RNA code for the FOX2 splicing regulator revealed by mapping
RNA-protein interactions in stem cells. Nat. Struct. Mol. Biol. 16, 130–137.
Zhang, C., and Darnell, R.B. (2011). Mapping in vivo protein-RNA interactions
at single-nucleotide resolution from HITS-CLIP data. Nat. Biotechnol. 29,
607–614.
Zhang, C., Zhang, Z., Castle, J., Sun, S., Johnson, J., Krainer, A.R., and Zhang,
M.Q. (2008). Defining the regulatory network of the tissue-specific splicing
factors Fox-1 and Fox-2. Genes Dev. 22, 2550–2563.
Zhang, C., Frias, M.A., Mele, A., Ruggiu, M., Eom, T., Marney, C.B., Wang, H.,
Licatalosi, D.D., Fak, J.J., and Darnell, R.B. (2010). Integrative modeling
defines the Nova splicing-regulatory network and its combinatorial controls.
Science 329, 439–443.
Zhang, C., Lee, K.-Y., Swanson, M.S., and Darnell, R.B. (2013). Prediction of
clustered RNA-binding protein motif sites in the mammalian genome. Nucleic
Acids Res. 41, 6793–6807.
